Actavis Totowa, LLC

Form 483 issued October 11, 2006 · Totowa, New Jersey

Inspection
Oct 11, 2006
Investigator
Kristy A. Zielny
Observations
3
Pages
3
FEI number
3003450194

In short: On October 11, 2006, FDA issued a Form 483 with 3 observations to Actavis Totowa, LLC in Totowa, New Jersey (FEI 3003450194) after an inspection that ran Oct 11, 2006. The investigator was Kristy A. Zielny. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.165 (testing and release for distribution).

At a glance

3 of 3 observations on this 483 concern laboratory controls.

Laboratory controls3

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Deviations from v,TÎtten specifications, test procedures, and laboratory…

  2. 02

    The accuracy, sensitivity, specificity, and reproducibility of test methods…

  3. 03

    Verification of the suitability of the testing methods is deficient in that they are not performed…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Actavis Totowa, LLC?

FDA listed 3 observations on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.165 (testing and release for distribution). The opening words of each observation are shown on this page.

Who inspected Actavis Totowa, LLC?

Kristy A. Zielny is named on this Form 483, for the inspection of Oct 11, 2006. Each investigator has a profile showing what they cite most.

When was Actavis Totowa, LLC inspected by FDA?

The inspection ran Oct 11, 2006, and the Form 483 is dated October 11, 2006.

How do I get the full Form 483 for Actavis Totowa, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free